Tuberculosis vaccine investigated to use against coronavirus

Sun Online Desk

31st March, 2020 11:55:30 printer

Tuberculosis vaccine investigated to use against coronavirus


A vaccine that’s been used to prevent tuberculosis is being given to health-care workers in Melbourne to see if it will protect them against the coronavirus.

The bacillus Calmette-Guerin, or BCG, shot has been used widely for about 100 years, with a growing appreciation for its off-target benefits. Not only is it a common immunotherapy for early-stage bladder cancer, it also seems to train the body’s first line of immune defense to better fight infections.

With an immunization specifically targeted against the pandemic-causing Covid-19 disease at least a year away, the World Health Organization says it’s important to know whether the BCG vaccine can reduce disease in those infected with the coronavirus, and is encouraging international groups to collaborate with a study led by Nigel Curtis, head of infectious diseases research, at the Murdoch Children’s Research Institute in Melbourne.

“It can boost the immune system so that it defends better against a whole range of different infections, a whole range of different viruses and bacteria in a lot more generalized way,” said Curtis, who’s also a professor of pediatric infectious diseases at the University of Melbourne and head of the infectious diseases unit at the city’s Royal Children’s Hospital.

Hospital staff who volunteered to be part of a six-month trial in Australia involving 4,000 health-care workers will be randomly allocated to be vaccinated starting Monday against seasonal influenza and TB, or the flu shot only.

Similar research is going on in the Netherlands.

Although the inexpensive vaccine, which is used to immunize some 130 million newborns worldwide each year, may potentially offer protection to a broader group of people, the priority is on health workers who are at higher risk from being infected with coronavirus while caring for sick patients.